CapsoVision (CV) Cash from Investing Activities (2024 - 2025)

CapsoVision (CV) posted Cash from Investing Activities of -$8000.0 for Q4 2025, up 33.33% sequentially from -$12000.0 in Q3 2025.

CapsoVision (CV) Cash from Investing Activities (2024 - 2025) Analysis & Trends

CapsoVision has reported Cash from Investing Activities for 2 years, with the latest figure at -$8000.0 in Q4 2025.

Quarterly Cash from Investing Activities changed N/A year-over-year to -$8000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$24000.0 (changed N/A YoY) and the FY2025 annual result came in at -$90000.0, up 41.18% from the prior year.
Cash from Investing Activities grew to -$8000.0 in Q4 2025 per CV's latest filing, from -$12000.0 in the prior quarter.
Over five years, Cash from Investing Activities peaked at -$4000.0 in Q3 2024 and troughed at -$12000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Activities (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	-673.00 Mn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	-639.00 Mn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	-917.00 Mn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	-1.96 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	-193.20 Mn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	329.80 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	-115.00 Mn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	-22.08 Mn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	-108.50 Mn
10	CapsoVision	299.87 Mn	290.80 Mn	1.87 Mn	-

Download Data